Variables | MACE n = 27 (30.3%) | no MACE n = 62 (69.7%) | P value |
---|---|---|---|
Location | Â | Â | 0.871 |
 LM, n (%) | 2 (7.4) | 8 (12.9) |  |
 LAD, n (%) | 16 (59.3) | 30 (48.4) |  |
 LCX, n (%) | 4 (14.8) | 13 (21.0) |  |
 RCA, n (%) | 5 (18.5) | 10 (16.1) |  |
 Ramus intermedius, n (%) | 0 (0) | 1 (1.6) |  |
Diameter stenosis, % (QCA) | 47.6 ± 8.1 | 42.2 ± 1.2 | 0.012 |
Grayscale IVUS | |||
 Diameter stenosis, % | 29.1 ± 10.9 | 26.7 ± 8.1 | 0.314 |
 Lesion length, mm | 13.1 ± 6.6 | 13.9 ± 7.7 | 0.609 |
 Area stenosis, % | 39.2 ± 16.7 | 35.7 ± 13.7 | 0.321 |
 Minimal luminal area, mm2 | 4.9 ± 1.6 | 5.8 ± 2.5 | 0.073 |
 Minimal luminal diameter, mm | 2.3 ± 0.3 | 2.4 ± 0.5 | 0.130 |
 Plaque burden, % | 66.0 ± 8.6 | 61.6 ± 9.9 | 0.045 |
 Reference area, mm2 | 8.4 ± 2.6 | 8.6 ± 3.2 | 0.806 |
 Lumen volume, mm3 | 92.9 ± 43.3 | 99.3 ± 57.0 | 0.607 |
 Plaque volume, mm3 | 119.8 ± 94.1 | 114.7 ± 76.8 | 0.790 |
 Remodeling index | 1.0 ± 0.1 | 1.0 ± 0.1 | 0.814 |
VH-IVUS | |||
 TCFA, n (%) | 7 (25.9) | 19 (30.6) | 0.653 |
 Fibrous area, mm2 | 4.4 ± 2.5 | 4.0 ± 2.3 | 0.472 |
 Fibrofatty area, mm2 | 1.5 ± 1.8 | 0.8 ± 0.8 | 0.047 |
 Dense calcium area, mm2 | 0.5 ± 0.5 | 0.5 ± 0.5 | 0.547 |
 Necrotic core area, mm2 | 1.2 ± 1.2 | 1.1 ± 0.9 | 0.774 |
 Percent fibrous area, % | 59.0 ± 13.9 | 61.2 ± 14.2 | 0.511 |
 Percent fibrofatty area, % | 15.6 ± 13.1 | 11.0 ± 7.8 | 0.101 |
 Percent dense calcium area, % | 7.6 ± 6.4 | 9.3 ± 9.3 | 0.394 |
 Percent necrotic core area, % | 17.9 ± 14.0 | 18.4 ± 10.7 | 0.845 |
 Fibrous volume, mm3 | 44.2 ± 46.6 | 42.7 ± 34.5 | 0.866 |
 Fibrofatty volume, mm3 | 13.2 ± 18.0 | 8.8 ± 11.2 | 0.166 |
 Dense calcium volume, mm3 | 5.5 ± 6.0 | 6.2 ± 6.2 | 0.639 |
 Necrotic core volume, mm3 | 11.1 ± 10.4 | 11.8 ± 9.7 | 0.784 |
 Percent fibrous volume, % | 61.2 ± 12.1 | 61.0 ± 11.5 | 0.966 |
 Percent fibrofatty volume, % | 14.9 ± 9.6 | 11.7 ± 7.4 | 0.093 |
 Percent dense calcium volume, % | 7.9 ± 6.8 | 9.3 ± 7.6 | 0.413 |
 Percent necrotic core volume, % | 16.0 ± 10.4 | 17.9 ± 9.7 | 0.400 |